Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2022, Vol. 27 ›› Issue (9): 1061-1066.doi: 10.12092/j.issn.1009-2501.2022.09.014

Previous Articles     Next Articles

Research progress of autophagy in intestinal ischemia-reperfusion injury

ZHANG Wei, WANG Yingbin, CAO Lu, LIU Yan, ZHANG Li, LIU Jieting   

  1. Department of Anesthesiology, Lanzhou University Second Hospital, Lanzhou 730030, Gansu, China 
  • Received:2022-07-19 Revised:2022-09-15 Online:2022-09-27 Published:2022-10-14

Abstract: Intestinal ischemia/reperfusion injury (II/RI) is a common pathological process in clinical practice. Ischemia/reperfusion causes damage to intestinal mucosa and distant organs, and induces systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS). Autophagy is a defense regulation mechanism under stress conditions, which can maintain the homeostasis of cytoplasm, proteins and organelles. The mechanism of autophagy is complex, which is co-regulated by protein complexes encoded by evolutionarily conserved autophagy-related gene (ATG) and a variety of signaling molecules and pathways. Studies have found that autophagy is involved in the process of intestinal ischemia-reperfusion injury. Therefore, revealing the mechanism of autophagy in II/RI can provide evidence for the prevention and treatment of II/RI.

Key words: autophagy, intestinal ischemia-reperfusion injury, molecular mechanism

CLC Number: